Multomic analysis reveals the potential of LAG3 as a prognostic and immune biomarker and its validation in osteosarcoma
Abstract Lymphocyte activation gene 3 (LAG3) is a member of the immunoglobulin superfamily and has been implicated in the development, growth, and progression of several cancers. However, the biological role of LAG3 has not been investigated in pan-cancer datasets. We sought to perform a comprehensi...
Saved in:
| Main Authors: | Qianqian Cao, Yuzhe Zhang, Cheng Cheng, Xiaoyang Wang, Panlong Fan, Jincheng Huang, Zhipeng Dai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-10290-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pan-cancer analysis reveals MTTP as a prognostic and immunotherapeutic biomarker in human tumors
by: Wenjia Wang, et al.
Published: (2025-03-01) -
Relation between the phase-lag index and lagged coherence for assessing interactions in EEG and MEG data
by: Rikkert Hindriks
Published: (2021-03-01) -
Lymphocyte activation gene 3 served as a potential prognostic and immunological biomarker across various cancer types: a clinical and pan‐cancer analysis
by: Yifan Liu, et al.
Published: (2024-01-01) -
Comprehensive multi-omics pan-cancer analysis revealed EGFLAM as a potential prognostic and immune infiltration-associated biomarker
by: Jian Yang, et al.
Published: (2025-07-01) -
NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses
by: Yusheng Liu, et al.
Published: (2025-05-01)